| |
|
|
|
Acelrx Pharmaceutica
|
|
3.35 +0.15 (+4.69%) |
9/22/2017 4:00pm |
|
Open: |
3.20 |
Pre close: |
3.20 |
Target:
|
4.03
|
|
High: |
3.35 |
Low: |
3.15 |
Resistance:
|
3.45
4.03
|
|
Volume: |
819,858 |
Market Cap: |
152.02M |
Support:
|
3.08
2.85
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.23
 |
MACD |
MACD(12,26):
|
0.05 |
|
MA(20): |
3.20 |
Signal(12,26,9): |
0.05 |
|
MA(100): |
2.78 |
Stochastic Oscillator |
%K(14,3):
|
60.00 |
|
MA(250): |
2.91  |
%D(3): |
53.33 |
|
Average Volume(K) |
3-Month: |
120296
|
52-Week |
High:
|
4.08 |
|
10-Days: |
52711 |
Low: |
1.95 |
|
RSI |
RSI(14):
|
60.22 |
Change(%): |
-7.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.100 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
45.38 |
|
EPS Est. Current Year |
-1.130 |
Return on Assets (ttm) |
-24.2 |
Shares Float (M) |
31.47 |
|
EPS Est. Next Year |
-0.830 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.78 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
-41.3 |
% Held by Institutions |
39.71 |
|
Forward EPS |
-0.831 |
Gross Profit (p.s.) |
0.111 |
Shares Short (K) |
4090 |
|
Book Value (p.s.) |
-0.700 |
EBITDA (p.s.) |
-0.775 |
P/E |
-3.05 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-4.79 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-31.23 |
P/S |
447126432.00 |
|
Operating Margin |
-238.47 |
Levered Free Cash Flow
(M) |
-28.95 |
P/CF |
-4.87 |
|
|
|
|
|
|
|
